标题
Silent corticotroph adenomas
作者
关键词
Silent corticotroph, Cushing, Pituitary adenoma, Nonfunctioning
出版物
Pituitary
Volume 21, Issue 2, Pages 183-193
出版商
Springer Nature
发表日期
2018-01-17
DOI
10.1007/s11102-018-0864-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
- (2017) Hélène Lasolle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study
- (2017) Or Cohen-Inbar et al. JOURNAL OF NEURO-ONCOLOGY
- Perioperative hypothalamic pituitary adrenal function in patients with silent corticotroph adenomas
- (2017) Abdelle F. Cheres et al. Pituitary
- Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review
- (2017) Fabienne Langlois et al. Pituitary
- Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
- (2017) Anat Ben-Shlomo et al. Current Opinion in Endocrinology Diabetes and Obesity
- Prevalence of clinically silent corticotroph macroadenomas
- (2016) Katie B. Guttenberg et al. CLINICAL ENDOCRINOLOGY
- ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres
- (2016) Michael W. O'Reilly et al. CLINICAL ENDOCRINOLOGY
- Recurrent gain-of-function USP8 mutations in Cushing's disease
- (2015) Zeng-Yi Ma et al. CELL RESEARCH
- The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
- (2015) Hiroshi Nishioka et al. ENDOCRINE PATHOLOGY
- Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up
- (2015) Georgia Ntali et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study
- (2015) Daniel S. Olsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy
- (2015) N. C. van Varsseveld et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease
- (2015) Luis G. Perez-Rivas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
- (2015) Filippo Ceccato et al. JOURNAL OF NEURO-ONCOLOGY
- ACTH adenomas transforming their clinical expression: report of 5 cases
- (2015) Matteo Zoli et al. Neurosurgical Focus
- Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas
- (2015) Ashley Di Meo et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy
- (2014) Olga Moshkin et al. Hormones-International Journal of Endocrinology and Metabolism
- Silent Corticotroph Adenomas After Stereotactic Radiosurgery: A Case–Control Study
- (2014) Zhiyuan Xu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Silent corticotroph adenomas
- (2014) Odelia Cooper Pituitary
- The Role of Mediators of Cell Invasiveness, Motility, and Migration in the Pathogenesis of Silent Corticotroph Adenomas
- (2013) Ozgur Mete et al. ENDOCRINE PATHOLOGY
- A Comprehensive Long-term Retrospective Analysis of Silent Corticotrophic Adenomas vs Hormone-Negative Adenomas
- (2013) Arman Jahangiri et al. NEUROSURGERY
- Clinical features of silent corticotroph adenomas
- (2012) Hussein Alahmadi et al. ACTA NEUROCHIRURGICA
- Silent Corticotroph Adenomas
- (2012) Adriana G. Ioachimescu et al. NEUROSURGERY
- Silent or Subclinical Corticotroph Pituitary Macroadenoma Transforming Into Cushing Disease
- (2012) Eugen Melcescu et al. NEUROSURGERY
- O-6-Methylguanine-DNA Methyltransferase (MGMT) Immunohistochemical Expression in Pituitary Corticotroph Adenomas
- (2011) Fateme Salehi et al. NEUROSURGERY
- Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas
- (2011) Filip Gabalec et al. Pituitary
- Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature
- (2011) A. K. Annamalai et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease
- (2010) Gérald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas
- (2010) Yuji Tani et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome
- (2010) Lukui Chen et al. JOURNAL OF NEURO-ONCOLOGY
- Identification and consequences of galectin-3 expression in pituitary tumors
- (2010) A. Righi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes
- (2010) Odelia Cooper et al. Hormones & Cancer
- Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas
- (2009) Hwa Young Cho et al. CLINICAL ENDOCRINOLOGY
- Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas
- (2009) Toru TATENO et al. ENDOCRINE JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started